Research Papers

25 of 2086 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
PSMA1, a Poor Prognostic Factor, Promotes Tumor Growth in Lung Squamous Cell Carcinoma.
Liu Z; Wang W; Zhou Y; Li L; Zhou W.
Dis Markers (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Silencing <i>MYOT</i> Expression May Inhibit Autophagy in Human Skeletal Muscle Cells.
Lin ZJ; Xu JM; Ji HY; Jiang YQ; Su J; Fan LL; Yu R.
Dis Markers (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Propofol-Induced miR-493-3p Inhibits Growth and Invasion of Gastric Cancer through Suppression of DKK1-Mediated Wnt/<i>…
Zhan K; Song X; Zhang Q; Yang J; Lu S.
Dis Markers (Unknown)
Published: 2023
2/6 Transparent
Screening of Biomarkers in Liver Tissue after Bariatric Surgery Based on WGCNA and SVM-RFE Algorithms.
Jiang Y; Wang Y; Chen S; Liu Z; Yang H; Jiao Y; Tang L.
Dis Markers (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Construction and Validation of a Novel Cuproptosis-Related Seven-lncRNA Signature to Predict the Outcomes, Immunotherap…
Zhang H; Ning Z; Wang B; Liu Y; Tao B; Zhang G; Liu H; Wang C.
Dis Markers (Unknown)
Published: 2023
4/6 Transparent
Code Funding Declared
TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment.
Zhu X; Zeng Z; Chen M; Chen X; Hu D; Jiang W; Du M; Chen T; Chen T; Liao W; Zhang C; Qu Y; Pan W.
Dis Markers (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Tanshinone IIA Inhibits Triple-Negative Breast Cancer Cells MDA-MB-231 via G Protein-Coupled Estrogen Receptor- (GPER-)…
He Y; Yang K; Liu J; Shi D; Zhang Z; Yang J; Chen M; Zhao P.
Dis Markers (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
lncRNA SSTR5-AS1 Predicts Poor Prognosis and Contributes to the Progression of Esophageal Cancer.
Hu Y; Mao N; Zheng W; Hong B; Deng X.
Dis Markers (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Inhibition of Mast Cell Degranulation in Atopic Dermatitis by Celastrol through Suppressing MRGPRX2.
Yao C; Ye W; Chen M.
Dis Markers (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation …
Tang X; Zhou H; Liu Y.
Dis Markers (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Recurrent-Specific Regulation Network of Prognostic Stemness-Related Signatures in Low-Grade Glioma.
Li J; Zhou M; Huang D; Lin R; Cui X; Chen S; Yao Y; Xian S; Wang S; Fu Q; Zhu J; Yue X; Huang R; Qi E; Huang Z.
Dis Markers (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Integrative Bioinformatics Analysis Identifies DDX60 as a Potential Biomarker for Systemic Lupus Erythematosus.
Chen W; Li ZY; Huang L; Zhou DH; Luo WQ; Zhang XF; Li L; Wen CP; Wang Q.
Dis Markers (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
TRIM58 Interacts with ZEB1 to Suppress NSCLC Tumor Malignancy by Promoting ZEB1 Protein Degradation via UPP.
Shang R; Chen J; Gao Y; Chen J; Han G.
Dis Markers (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Analysis of 17 Prenatal Cases with the Chromosomal 1q21.1 Copy Number Variation.
Wen X; Xing H; Qi K; Wang H; Li X; Zhu J; Chen W; Cui L; Zhang J; Qi H.
Dis Markers (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene <i>DA…
Ju G; Zhang L; Guo W; Wang H; Zhang X; Mu Z; Sun Y; Sun D; Diao H; Miao S; Chen Y; Xing T; Liang J; Lin Y.
Dis Markers (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma.
Fan Z; Sun X; Sun X; Li K; Zhang Y; Zuo S; Li C; Wan S; Huang D.
Dis Markers (Unknown)
Published: 2022
2/6 Transparent
ROMA Index Is an Effective Predictor for Advanced Endometrial Cancer before Surgery.
Wang J; Xu P; Zou G; Yin M; Mao X; Zhang X.
Dis Markers (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Prognostic Value of Lymphocyte-to-Monocyte Ratio (LMR) in Cancer Patients Undergoing Immune Checkpoint Inhibitors.
Wan L; Wu C; Luo S; Xie X.
Dis Markers (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Risk Score for Prediction of Acute Kidney Injury in Patients with Acute ST-Segment Elevation Myocardial Infarction.
Zhao H; Miao R; Lin F; Zhao G.
Dis Markers (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Tanshinone IIA Improves Acute Gouty Arthritis in Rats through Regulating Neutrophil Activation and the NLRP3 Inflammaso…
Xu L; Liu X; Zhang Y; Jia T; Li L; Du Y; Chen W; Zhang S.
Dis Markers (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
A Novel Inflammatory and Nutritional Prognostic Scoring System for Nonpathological Complete Response Breast Cancer Pati…
Jiang C; Xiu Y; Zhang S; Yu X; Qiao K; Huang Y.
Dis Markers (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Relationship of Admission Serum Anion Gap and Prognosis of Critically Ill Patients: A Large Multicenter Cohort Study.
Li R; Jin X; Ren J; Deng G; Li J; Gao Y; Zhang J; Du L; Liu J; Liu X; Wang X; Wang G.
Dis Markers (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Antiresistin Neutralizing Antibody Alleviates Doxorubicin-Induced Cardiac Injury in Mice.
Hu Y; Wang J; Du W; Wu N; Wang S; Zhang C; Chen X; Shen C.
Dis Markers (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Qingfei Tongluo Formula Mitigates <i>Mycoplasma pneumoniae</i> Infection via the PERK Signaling Pathway.
Liu X; Wang M; Kan Q; Lin Y; Jiang Z.
Dis Markers (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The Number of Positive Tumor Markers (NPTM) Achieves Higher Value in the Prognosis Prediction of Gastric Cancer.
Li L; Ma B; Liu F; Sheng C; Peng Y; Qiao Y; Wang P; Chen K; Song F.
Dis Markers (Unknown)
Published: 2022
3/6 Transparent
Funding Declared